Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SEL PHARMACIE GABAUDE RESPLANDY : revenue, balance sheet and financial ratios

SEL PHARMACIE GABAUDE RESPLANDY is a French company founded 14 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MERIGNAC (33700), this company of category PME shows in 2024 a net income positive of 146 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SEL PHARMACIE GABAUDE RESPLANDY (SIREN 537702250)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 145 631 € 169 673 € 417 157 € 591 422 € 79 096 € 162 574 € 127 416 € 100 557 € 124 552 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SEL PHARMACIE GABAUDE RESPLANDY generates positive net income of 146 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 125 k€ -> 146 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

145 631 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 144%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

144.081%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

37.151%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

47.6%

Solvency indicators evolution
SEL PHARMACIE GABAUDE RESPLANDY

Sector positioning

Debt ratio
144.08 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average

In 2024, the debt ratio of SEL PHARMACIE GABAUDE RES... (144.08) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
37.15% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +10 pts over 3 years

In 2024, the financial autonomy of SEL PHARMACIE GABAUDE RES... (37.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 179.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

179.737

Liquidity indicators evolution
SEL PHARMACIE GABAUDE RESPLANDY

Sector positioning

Liquidity ratio
179.74 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average +6 pts over 3 years

In 2024, the liquidity ratio of SEL PHARMACIE GABAUDE RES... (179.74) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 27 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 624 days. Excellent situation: suppliers finance 597 days of the operating cycle (retail model).

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

27 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

624 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SEL PHARMACIE GABAUDE RESPLANDY

Positioning of SEL PHARMACIE GABAUDE RESPLANDY in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SEL PHARMACIE GABAUDE RESPLANDY is estimated at 2 033 116 € (range 1 415 830€ - 3 041 658€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1415k€ 2033k€ 3041k€
2 033 116 € Range: 1 415 830€ - 3 041 658€
NAF 5 année 2024

Valuation method used

Net Income Multiple
145 631 € × 14.0x = 2 033 116 €
Range: 1 415 830€ - 3 041 658€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SEL PHARMACIE GABAUDE RESPLANDY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SEL PHARMACIE GABAUDE RESPLANDY

What is the revenue of SEL PHARMACIE GABAUDE RESPLANDY ?

The revenue of SEL PHARMACIE GABAUDE RESPLANDY is not publicly disclosed (confidential accounts filed with INPI).

Is SEL PHARMACIE GABAUDE RESPLANDY profitable?

Yes, SEL PHARMACIE GABAUDE RESPLANDY generated a net profit of 146 k€ in 2024.

Where is the headquarters of SEL PHARMACIE GABAUDE RESPLANDY ?

The headquarters of SEL PHARMACIE GABAUDE RESPLANDY is located in MERIGNAC (33700), in the department Gironde.

Where to find the tax return of SEL PHARMACIE GABAUDE RESPLANDY ?

The tax return of SEL PHARMACIE GABAUDE RESPLANDY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SEL PHARMACIE GABAUDE RESPLANDY operate?

SEL PHARMACIE GABAUDE RESPLANDY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.